Advanced Malignancies
Showing NaN - NaN of 7
Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)
Completed
- Advanced Malignancies
- Metastatic Cancer
- INCAGN01876
- +2 more
-
Los Angeles, California
- +37 more
Dec 6, 2022
All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,
Active, not recruiting
- All Malignancies
- +11 more
- Tazemetostat
- +2 more
-
Encinitas, California
- +9 more
May 20, 2022
Advanced Malignancies Trial in Worldwide (Tislelizumab 200 mg, IV, Pamiparib 20, 40, 60 mg PO Twice Daily (BID), Pemetrexed 500
Enrolling by invitation
- Advanced Malignancies
- Tislelizumab 200 mg, IV
- +4 more
-
Miami Beach, Florida
- +50 more
Mar 4, 2022
Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020
